Related Experiment Video
Updated: Jun 15, 2026

Visualizing and Quantifying Endonuclease-Based Site-Specific DNA Damage
Published on: August 21, 2021
Targeting and processing of site-specific DNA interstrand crosslinks
1Department of Carcinogenesis, The University of Texas M.D. Anderson Cancer Center, Science Park-Research Division, Smithville, Texas 78957, USA. kvasquez@mdanderson.org
DNA interstrand crosslinks (ICLs) are highly toxic DNA lesions. Understanding their repair mechanisms, particularly involving nucleotide excision repair (NER), mismatch repair (MMR), and homologous recombination (HR), can improve cancer drug efficacy.
Area of Science:
- Molecular Biology
- Genetics
- Cancer Research
Background:
- DNA interstrand crosslinks (ICLs) are cytotoxic DNA lesions formed endogenously or by chemotherapy agents.
- ICL-inducing drugs are effective anticancer treatments but can cause secondary malignancies due to DNA lesion processing.
- ICL repair mechanisms are better understood in simpler organisms than in mammalian cells.
Purpose of the Study:
- To review the roles of nucleotide excision repair (NER), mismatch repair (MMR), and homologous recombination (HR) proteins in mammalian ICL repair.
- To explore the potential of targeted ICL induction using psoralen-linked oligonucleotides for cancer therapy.
Main Methods:
- Literature review focusing on NER, MMR, and HR pathways in ICL processing.
- Discussion of ICL repair mechanisms in human cells and mice.
- Examination of novel therapeutic strategies for targeted ICL induction.
Main Results:
- ICLs are repaired through a complex interplay of multiple DNA repair pathways, including NER, MMR, and HR.
- Specific proteins within NER, MMR, and HR pathways are critical for processing ICLs in mammalian cells.
- Targeted ICL induction offers a potential strategy to enhance chemotherapeutic efficacy.
Conclusions:
- A deeper understanding of ICL repair pathways is crucial for optimizing cancer therapy and minimizing side effects.
- Investigating the coordinated action of NER, MMR, and HR proteins in ICL repair holds promise for improving drug development.
- Site-specific ICL induction represents an innovative approach to cancer treatment.
Related Concept Videos
Homologous Recombination
Fixing Double-strand Breaks
Fixing Double-strand Breaks
Nucleotide Excision Repair
Nucleotide Excision Repair
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
Long-patch Base Excision Repair

